On September 18, the U.S. Food and Drug Administration (FDA) approved Opioid Analgesic Risk Evaluation and Mitigation Strategy plan, which for the first time applies to immediate-release opioid analgesics intended for use in an outpatient setting. Read more via Food & Drug Administration.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
